Mobocertinib - Takeda
At a glance
- Drug Originator ARIAD Pharmaceuticals
- Drug Class Amides; Antineoplastics; Dimethylamines; Esters; Ethers; Indoles; Pyrimidines; Small molecules
- Mechanism of Action BLK protein inhibitors; Epidermal growth factor receptor antagonists; ERBB 2 receptor antagonists; ERBB 4 receptor antagonists
- USA Patent Applicants TAKEDA PHARMS USA
- USA Patents 3
- NDAs 1
- International Patents 63
- Patent Applications 9
Table of Contents
Disclaimer